Clinical Trials on Mycoplasma Infections

Total 56752 results

GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older

Herpes Zoster

United States, Germany, Estonia, Canada
Maruho Co., Ltd.

Completed

Phase III Study of ASP2151 in Herpes Zoster Patients

Herpes Zoster

Japan
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years

Herpes Zoster

Japan
GlaxoSmithKline

Completed

Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older

Herpes Zoster

United States, Estonia
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant

Herpes Zoster

Spain, Taiwan, Italy, Canada, Belgium, Finland, Korea, Republic of, Panama, Czechia
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults

Herpes Zoster

Australia
GlaxoSmithKline

Completed

Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A

Herpes Zoster

United States, Australia, France, Spain, Finland, Estonia, Russian Federation, Taiwan, Belgium, Korea, Republic of, Czechia, Germany, Hong Kong, Israel, Turkey, United Kingdom, Greece, Romania, Netherlands, Italy, South Africa, Ca... and more
GlaxoSmithKline

Completed

Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A

Herpes Zoster

United States
Yung Shin Pharm. Ind. Co., Ltd.

Completed

A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster (Vacyless®)

Herpes Zoster

Taiwan
Toi Labs, Inc.

Completed

Creation of an E-toileting Log Through Classification of the Physical Properties of Stool and Urine Using TrueLoo™

Urinary Tract Infections | Clostridium Difficile Infection | Gastrointestinal Disease | GastroIntestinal Bleeding | Infectious Diarrhea

United States
Enanta Pharmaceuticals, Inc

Recruiting

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. (RSVHR)

RSV Infection

United States, Poland, Spain, Taiwan, Bulgaria, Argentina, Puerto Rico, Czechia, Brazil, Israel, Malaysia, Netherlands, Slovakia, South Africa
Enanta Pharmaceuticals, Inc

Terminated

Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Who Are Infected With Acute Respiratory Syncytial Virus (RSV) of the Upper Respiratory Tract (RSVTx)

Respiratory Syncytial Virus Infections

Spain, Korea, Republic of, Israel, Canada, United States, Italy, France, Belgium, Brazil, Taiwan, Greece, Argentina, Mexico, South Africa, China, Poland, Colombia, Turkey, United Kingdom
Hospital Virgen de la Luz

Terminated

Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection

Tuberculosis

Spain
Federal State Budgetary Organization, Federal Center...

Completed

Microbiological Structure of Pathogens of Periprosthetic Infection of Large Joints in the Post-Covid Period

Joint Infection | Periprosthetic Left Knee Joint Infection

Russian Federation
Duke University
Biomedical Advanced Research and Development Authority

Completed

Infection Watch Study (CovIdentify)

Respiratory Syncytial Virus Infections | COVID-19 Respiratory Infection | Influenza Viral Infections | Rhinoviral Infections

United States
Basilea Pharmaceutica

Completed

Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

Skin Diseases, Infectious | Staphylococcal Skin Infections | Skin Diseases, Bacterial
Basilea Pharmaceutica

Completed

Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

Skin Diseases, Infectious | Staphylococcal Skin Infections | Skin Diseases, Bacterial
London School of Hygiene and Tropical Medicine
Liverpool School of Tropical Medicine; Kamuzu University of Health Sciences; Malawi-Liverpool-Wellcome...

Completed

Computer Aided Screening for Tuberculosis in Low Resource Environments (CASTLE)

HIV Infections | Tuberculosis Infection

Malawi
Altimmune, Inc.

Terminated

NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)

Coronavirus Infection

United States
Azienda Ospedaliero, Universitaria Pisana

Completed

Probiotics Role in HPV Cervico-vaginal Infection Clearance

HPV Infection | Vaginal Infection

Italy
Bayside Health
Merck Sharp & Dohme LLC

Unknown

Universal Prophylaxis Versus Pre-emptive Therapy With Posaconazole Post-Lung Transplant (UPPRITE)

Fungal Infection

Australia
Baylor College of Medicine
National Heart, Lung, and Blood Institute (NHLBI); The Methodist Hospital Research... and other collaborators

Completed

Administration of Virus-Specific Cytotoxic T-Lymphocytes (LYPTAIST)

Adenovirus Infection

United States
AO Research Institute Davos

Completed

Gut Microbiome of Patients Undergoing Antibiotic Therapy for Orthopedic Device-related Infection (IMPAT-ODRI)

Fractures, Bone | Infection, Bacterial | Bone Infection | Joint Infection

Switzerland
Huashan Hospital
Guizhou Center for Disease Control and Prevention

Recruiting

Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients

Tuberculosis | Latent Tuberculosis Infection

China
McGill University
Canadian Institutes of Health Research (CIHR)

Completed

Enhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and Treatment (ACT4)

Latent Tuberculosis Infection

Canada, Ghana, Benin, Indonesia, Vietnam
Germans Trias i Pujol Hospital
Fondo de Investigacion Sanitaria

Unknown

Demonstration of the Dynamic Hypothesis of Latent Tuberculosis Infection (HYPDYN)

Latent Tuberculosis Infection

Spain
Universidad Autonoma de Nuevo Leon

Completed

Spinal Infection Management With Structural Allograft

Syndrome | Bone Diseases, Infectious | Allografts | Disease of Bone | Spine Infection | Bone Graft; Complications, Fracture

Mexico
Sanofi Pasteur, a Sanofi Company

Recruiting

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

Healthy Volunteers | Respiratory Syncytial Virus Infection | Metapneumovirus Infection

Australia, United States
Hospices Civils de Lyon
Exeliom Biosciences

Recruiting

Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients (LIVEDIFF)

Clostridioides Difficile Infection | Recurrent Infection

France
Labo'Life

Recruiting

Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection (EBVAST)

EBV Infection

Belgium
University of Pittsburgh
Merck Sharp & Dohme LLC

Withdrawn

Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI)

Clostridium Difficile Infection (CDI)

United States
McGill University
Université de Montréal

Terminated

Lubricant Investigation in Men to Inhibit Transmission of HPV Infection (LIMIT-HPV)

Human Papillomavirus Infection

Canada
Affiliated Hospital to Academy of Military Medical...

Unknown

Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in China

Viral Infection

China
University of Cape Town
London School of Hygiene and Tropical Medicine; Johns Hopkins University; Imperial... and other collaborators

Completed

Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons (HAART-IPT)

HIV Infections | Tuberculosis | Latent Tuberculosis Infection

South Africa
Vedanta Biosciences, Inc.

Completed

Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection (CONSORTIUM)

Clostridium Difficile Infection | Clostridium Difficile Infection Recurrence | Clostridium Difficile | CDI | Clostridioides Difficile Infection | Clostridioides Difficile | Clostridioides Difficile Infection Recurrence

United States, Canada
Curevo Inc
Green Cross Corporation; Mogam Biotechnology Research Institute

Active, not recruiting

Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older

Herpes Zoster | Shingles

United States
ModernaTX, Inc.

Recruiting

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

Cytomegalovirus Infection

United States
ModernaTX, Inc.

Active, not recruiting

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

Cytomegalovirus Infection

United States, Australia, Canada, France, Belgium, Germany, Israel, Italy, United Kingdom, Spain, Estonia, Finland, Japan
Radboud University Medical Center

Completed

Pharmacokinetics of Micafungin in Patients Intensive Care Unit (MIMIC)

Invasive Fungal Infection

Netherlands
Assistance Publique Hopitaux De Marseille

Completed

Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients (2006/25)

Cytomegalovirus Infection

France
Washington University School of Medicine
Hoffmann-La Roche

Completed

Study of Prophylactic Vs Preemptive Valganciclovir

Cytomegalovirus Infection

United States
Henry M. Jackson Foundation for the Advancement...
Centers for Disease Control and Prevention

Completed

Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees

Staphylococcus Aureus | Staphylococcal Skin Infections | MRSA Skin Infections

United States
Uniformed Services University of the Health Sciences

Completed

Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates

Staphylococcus Aureus | Staphylococcal Skin Infections | Community-Acquired Infections

United States
Hospices Civils de Lyon

Recruiting

Quality of Life in Patients Having a Prosthetic Joint Infection (QuaVIPA)

Quality of Life | Prosthetic Joint Infection

France
Shanghai Ark Biopharmaceutical Co., Ltd.
Ark Biosciences Pty Ltd.

Completed

Viral Inhibition in Children for Treatment of RSV (VICTOR)

RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

Australia, Hong Kong, Israel, Lebanon, Malaysia, Poland, Taiwan, Turkey
Rabin Medical Center

Completed

Optimal Antibiotic Treatment of Moderate to Severe Bacterial Infections (CDSS)

Nosocomial Infections | Community-associated Infections | Health-care Acquired Infections

Israel
Brigham and Women's Hospital

Active, not recruiting

Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 (VITAL Infection)

Infections | Human Cathelicidin Antimicrobial Peptide (hCAP-18)

United States
Baylor College of Medicine
National Institute of Allergy and Infectious Diseases (NIAID); George Washington...

Completed

Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection

Hookworm Infections

United States
MJM Bonten
Universiteit Antwerpen; Universitätsklinikum Köln; Da Volterra

Completed

AssessmeNT of the Incidence of Clostridium Difficile Infections in Hospitalized Patients on Antibiotic TrEatment (ANTICIPATE)

Clostridium Difficile

Germany, Spain, France, Greece, Netherlands, Romania
Astellas Pharma Europe Ltd.
Cubist Pharmaceuticals LLC

Terminated

A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System (FREEDOM)

Clostridium Difficile

Spain, France, Germany, Greece, Denmark, Austria, Poland

Clinical Trials on Mycoplasma Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations